SCHEDULE 13D/A: Veea Inc. CEO Allen Salmasi and NLabs Inc. Disclose Significant Ownership Stake and New Option Grant Following Business Combination

Veea Inc.'s CEO, Allen Salmasi, and NLabs Inc. have filed an amended Schedule 13D, revealing a combined beneficial ownership of 48.3% of Veea's common stock, including a recent grant of 3,036,308 stock options to Mr. Salmasi.

Summary

• Allen Salmasi and NLabs Inc. collectively beneficially own 18,921,792 shares of Veea Inc. Common Stock, representing approximately 48.3% of the 36,202,798 outstanding shares as of January 7, 2025.
• Mr. Salmasi's beneficial ownership includes 437,029 shares directly owned, 3,036,308 shares issuable upon option exercise, 12,148,921 shares held by NLabs Inc. (where Mr. Salmasi is CEO and stockholder), 2,808,475 shares held by Salmasi 2004 Trust, and 491,059 shares held by Mr. Salmasi's spouse.
• The majority of these shares were acquired through a Business Combination consummated on September 13, 2024, where Private Veea Shares converted into Veea Inc. Common Stock at a ratio of 0.1962 shares per Private Veea Share.
• As a result of the Business Combination, Mr. Salmasi received 437,029 shares and NLabs Inc. received 12,148,921 shares.
• On December 30, 2024, Mr. Salmasi was granted a fully-vested option to purchase 3,036,308 shares of Common Stock at an exercise price of $3.89 per share, which expires on December 29, 2028.
• Additionally, on September 13, 2024, notes totaling $15,739,897 in principal and accrued interest were converted into 3,147,970 shares of Common Stock at a per share value of $5.00, with these shares subject to a five-month lock-up period.

Sentiment

Score: 6

Explanation: The document is a factual disclosure of ownership and corporate actions (business combination, option grant). The significant ownership stake by the CEO and related entities, along with the option grant, can be seen as a positive for alignment of interests, contributing to a slightly positive sentiment, but the document itself is neutral in tone and does not present financial performance.

Positives

• The CEO, Allen Salmasi, and related entities hold a substantial beneficial ownership stake of 48.3% in Veea Inc., indicating strong alignment of interests with the company's performance.
• The grant of a fully-vested option for 3,036,308 shares to the CEO further aligns his incentives with long-term shareholder value.
• The completion of the Business Combination and conversion of $15,739,897 in notes into equity strengthens the company's capital structure by reducing debt.

Future Outlook

The Reporting Persons currently have no specific plans or proposals to acquire additional shares or to dispose of Common Stock. However, they may, at any time and from time to time, acquire or dispose of shares based on their ongoing evaluation of their investment, prevailing market conditions, other investment opportunities, and other investment considerations, subject to the Lock-Up Agreement.

Management Comments

• "Mr. Salmasi serves as Chief Executive Officer and chairman of the board of directors of the Issuer, and in such capacity may have the ability to influence the Issuer's management and operations directly in his position."
• "Although the Reporting Persons do not have any specific plan or proposal to acquire additional shares or to dispose of Common Stock, consistent with their investment purpose, the Reporting Persons may at any time and from time to time acquire additional shares of Common Stock or, subject to the Lock-Up Agreement (as defined below), dispose of shares of Common Stock, depending upon their ongoing evaluation of their investment, prevailing market conditions, other investment opportunities, and/or other investment considerations."

Industry Context

This filing primarily details changes in beneficial ownership and corporate control following a SPAC business combination. It reflects the post-merger ownership structure and management's stake, which is common for newly public companies or those undergoing significant corporate transactions. It does not provide information to analyze broader industry trends or competitive positioning.

Corporate Governance

Legal Proceedings

• No Reporting Person has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors) during the past five years.
• No Reporting Person was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in a judgment, decree, or final order enjoining future violations of, or prohibiting, or mandating activities subject to, federal or state securities laws or a finding of any violation with respect to such laws during the past five years.

Related Party Transactions

• Allen Salmasi, as Chief Executive Officer and Chairman of the board of directors, received a fully-vested option to purchase 3,036,308 shares of Common Stock at an exercise price of $3.89 per share on December 30, 2024.
• Shares held by Mr. Salmasi's spouse (491,059 shares) and the Salmasi 2004 Trust (2,808,475 shares), where Mr. Salmasi's spouse is the trustee, are included in Mr. Salmasi's beneficial ownership.
• NLabs Inc., of which Mr. Salmasi is the Chief Executive Officer and stockholder, holds 12,148,921 shares of Common Stock, contributing significantly to Mr. Salmasi's overall beneficial ownership.

Stakeholder Impact

• Shareholders: The filing clarifies the significant beneficial ownership of the CEO and related entities, which could be viewed positively for management alignment. The lock-up agreements provide temporary stability by restricting immediate sales by certain insiders and pre-merger shareholders. The registration rights agreement provides a pathway for future liquidity for major shareholders.
• Management/Employees: The CEO's substantial equity stake and new option grant provide strong incentives for long-term performance and alignment with company success.

Next Steps

• The 180-day lock-up period for certain equity securities issued pursuant to the Business Combination Agreement will expire.
• The five-month lock-up period for shares issued from note conversion will expire.
• Allen Salmasi's option to purchase 3,036,308 shares expires on December 29, 2028.

Key Dates

Keywords

Veea Inc., Allen Salmasi, NLabs Inc., Schedule 13D, beneficial ownership, common stock, stock options, business combination, SPAC merger, Plum Acquisition Corp. I, corporate governance, lock-up agreement, registration rights